JNJ Shares Outstanding
Total shares outstanding each quarter, showing dilution from issuance or reduction from buybacks.
Shares Outstanding
Latest: 2.41B (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | 2.67B |
| 2020Q4 | 2.63B |
| 2021Q1 | 2.67B |
| 2021Q2 | 2.67B |
| 2021Q3 | 2.67B |
| 2021Q4 | 2.63B |
| 2022Q1 | 2.67B |
| 2022Q2 | 2.67B |
| 2022Q3 | 2.66B |
| 2022Q4 | 2.61B |
| 2023Q1 | 2.61B |
| 2023Q2 | 2.63B |
| 2023Q3 | 2.55B |
| 2023Q4 | 2.41B |
| 2024Q1 | 2.43B |
| 2024Q2 | 2.42B |
| 2024Q3 | 2.43B |
| 2024Q4 | 2.41B |
| 2025Q1 | 2.42B |
| 2025Q2 | 2.42B |
| 2025Q3 | 2.43B |
| 2025Q4 | 2.41B |
| 2026Q1 | 2.45B |
| 2026Q2 | 2.41B |
* In some reporting periods, diluted weighted-average shares are used instead of period-end shares outstanding. Please verify individual figures against the company's SEC filings.
Other JNJ Charts
More quarter-by-quarter fundamentals for Johnson & Johnson
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Shares Outstanding
Shares Outstanding
Shares Outstanding
Latest Shares Outstanding: 2.41B (2026Q2); -0.4% YoY; -0.9% CAGR since 2011Q1 (15.25y).
Across the 62 quarters from 2011Q1 to 2026Q2, Shares Outstanding ranged from 2.41B in 2023Q4 to 2.89B in 2013Q2.
Chart and table show the latest 24 of 62 quarters.